Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Pérez-Martínez, Antonio  [Clear All Filters]
2024
Echecopar C, Abad I, Galán-Gómez V, Del Castillo YMozo, Sisinni L, Bueno D, Ruz B, Pérez-Martínez A. An artificial intelligence-driven predictive model for pediatric allogeneic hematopoietic stem cell transplantation using clinical variables. Eur J Haematol. 2024.
Echecopar C, Rey IDel Val, Galán-Gómez V, González-Pérez C, Del Castillo YMozo, Martínez BGonzález, Pérez-Martínez A. The paradigm of total body irradiation in acute lymphoblastic leukaemia: Therapeutic effectiveness versus the challenges of toxicity. An Pediatr (Engl Ed). 2024.
Ascunce M, Coccolo A, Mozo Y, Baquero-Artigao F, Rodriguez-Molino P, Toro-Rueda C, García-Clemente P, Sánchez-Zapardiel E, López-Granados E, Corral-Sánchez D, et al. Severe Impairment of T-cell Immunity and Pulmonary GvHD Are Major Risk Factors for Nontuberculous Mycobacterial Infection After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Pediatr Infect Dis J. 2024.
2023
Gabelli M, Pérez-Martínez A, Sánchez DBueno, Lucchini G, Grenier L-P, Couture F, Limerick E, Bernaud V, Del Castillo MTrabazo, Ngwube A. Abatacept treatment for autoimmune hemolytic anemia occurring post hematopoietic stem cell transplantation. Bone Marrow Transplant. 2023.
Quintero V, Bueno-Sánchez D, Del Castillo YMozo-, Urtasun-Erburu A, Sisinni L, López-Duarte M, Pérez-Hurtado JMaría, Fuster JLuis, González-Vicent M, Pérez-Martínez A, et al. Haploidentical haematopoietic stem cell transplant in paediatric patients with acquired hypocellular bone marrow failures. Transplant Cell Ther. 2023.
Solano C, Castro-Rebollo P, Pérez-Martínez A, López-Corral L, Barba-Suñol P, Kwon M, Ortiz V, Sanz-Caballer J, Caballero ACarolina, Martínez J, et al. Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study. BMJ Open. 2023;13(7):e071371.
Gonzaga A, Andreu E, Hernández-Blasco LM, Meseguer R, Al-Akioui-Sanz K, Soria-Juan B, Sanjuan-Gimenez JCarlos, Ferreras C, Tejedo JR, Lopez-Lluch G, et al. Rationale for combined therapies in severe-to-critical COVID-19 patients. Front Immunol. 2023;14:1232472.
Sanchez-Guijo F, Avendaño-Solá C, Badimon L, Bueren JA, Canals JM, Delgadillo J, Delgado J, Eguizabal C, Fernández-Santos M-E, García-Olmo D, et al. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV). Bone Marrow Transplant. 2023.
Ochoa-Fernández B, Galán-Gómez V, Guerra-García P, Sanromán S, Martínez I, Bueno D, Mozo Y, Sisinni L, Losantos I, González B, et al. Younger age and induction failure predict outcomes in infant leukemia: 30 years of experience in a tertiary center. Front Pediatr. 2023;11:1166176.
2022
Olivas-Mazón R, Bueno D, Sisinni L, Mozo Y, Casado-Abad G, Pérez-Martínez A. A retrospective study of treosulfan versus busulfan-based conditioning in pediatric patients. Eur J Haematol. 2022.
2021
Gasior M, Ferreras C, de Paz R, Bueno D, Mozo Y, Sisinni L, Canizales JTorres, González B, Olivas-Mazón R, Marcos A, et al. The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation. Transfusion. 2021.
Kabat MGasior, Bueno D, Sisinni L, de Paz R, Mozo Y, Perona R, Arias-Salgado EG, Rosich B, Marcos A, Romero ABelén, et al. Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases. Int J Hematol. 2021.
2020
Urbán JGarcia, Gurrado K, Rivas PCBrea, Elrous DAbou, Machain MZubimendi, Gómez MRomero, Rodríguez JGarcía, Plaza BVicandi, Gregorio LYébenes, Fernández EGarcía, et al. A case-control study to assess the role of polyomavirus in transplant complications: Where do we stand?. Transpl Infect Dis. 2020:e13432.
Van Den Rym A, Taur P, Martinez-Barricarte R, Lorenzo L, Puel A, Gonzalez-Navarro P, Pandrowala A, Gowri V, Safa A, Toledano V, et al. Human BCL10 Deficiency due to Homozygosity for a Rare Allele. J Clin Immunol. 2020.
2019
García-Gómez S, Chaparro R, Safa A, Van Den Rym A, Martinez-Barricarte R, Lorenzo L, Sánchez-Ramón S, Toledano V, Cubillos-Zapata C, López-Collazo E, et al. Double-strand break repair through homologous recombination in autosomal recessive BCL10 deficiency. J Allergy Clin Immunol. 2019.
2018
Escudero A, Romera IMartínez, Fernández L, Valentín J, González-Vicent M, Vicario JLuis, Jarabo RMadero, Díaz MÁngel, Pérez-Martínez A. Donor KIR genotype impacts on clinical outcome after T-cell depleted HLA matched related allogeneic transplantation for high-risk pediatric leukemia patients. Biol Blood Marrow Transplant. 2018.
Perruccio K, Sisinni L, Pérez-Martínez A, Valentín J, Capolsini I, Massei MSperanza, Caniglia M, Cesaro S. High incidence of early human Herpes Virus-6 infection in children undergoing haploidentical manipulated stem cell transplantation for haematological malignancies. Biol Blood Marrow Transplant. 2018.
2015
Pérez-Martínez A, Fernández L, Valentín J, Martínez-Romera I, Corral MDolores, Ramírez M, Abad L, Santamaría S, González-Vicent M, Sirvent S, et al. A phase I/II trial of interleukin-15-stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors. Cytotherapy. 2015.
2013
Fernández L, Portugal R, Valentín J, Martín R, Maxwell H, González-Vicent M, Díaz MÁngel, de Prada I, Pérez-Martínez A. In vitro Natural Killer Cell Immunotherapy for Medulloblastoma. Front Oncol. 2013;3:94.